Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 1
1982 2
1985 2
1987 5
1988 4
1989 5
1990 7
1991 4
1992 11
1993 6
1994 6
1995 3
1996 9
1997 5
1998 5
1999 2
2000 5
2001 7
2002 8
2003 2
2004 7
2005 6
2006 4
2007 7
2008 5
2009 8
2010 9
2011 6
2012 5
2013 7
2014 7
2015 4
2016 5
2017 15
2018 17
2019 16
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

229 results
Results by year
Filters applied: . Clear all
Page 1
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators. Khorana AA, et al. Among authors: wun t. N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630. N Engl J Med. 2019. PMID: 30786186 Clinical Trial.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update.
Mahajan A, Brunson A, White R, Wun T. Mahajan A, et al. Among authors: wun t. Semin Thromb Hemost. 2019 Jun;45(4):321-325. doi: 10.1055/s-0039-1688494. Epub 2019 Apr 30. Semin Thromb Hemost. 2019. PMID: 31041801 Review.
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Cohen AT, et al. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096. N Engl J Med. 2013. PMID: 23388003 Free article. Clinical Trial.
How I diagnose and treat venous thromboembolism in sickle cell disease.
Shet AS, Wun T. Shet AS, et al. Among authors: wun t. Blood. 2018 Oct 25;132(17):1761-1769. doi: 10.1182/blood-2018-03-822593. Epub 2018 May 15. Blood. 2018. PMID: 29764840 Free PMC article. Review.
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
Liem RI, Lanzkron S, D Coates T, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA. Liem RI, et al. Among authors: wun t. Blood Adv. 2019 Dec 10;3(23):3867-3897. doi: 10.1182/bloodadvances.2019000916. Blood Adv. 2019. PMID: 31794601 Free PMC article.
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Khorana AA, Vadhan-Raj S, Kuderer NM, Wun T, Liebman H, Soff G, Belani C, O'Reilly EM, McBane R, Eikelboom J, Damaraju CV, Beyers K, Dietrich F, Kakkar AK, Riess H, Peixoto RD, Lyman GH. Khorana AA, et al. Among authors: wun t. Thromb Haemost. 2017 Nov 1;117(11):2135-2145. doi: 10.1160/TH17-03-0171. Epub 2017 Sep 21. Thromb Haemost. 2017. PMID: 28933799 Free PMC article. Clinical Trial.
Biomarkers of Cancer-Associated Thromboembolism.
Mahajan A, Wun T. Mahajan A, et al. Among authors: wun t. Cancer Treat Res. 2019;179:69-85. doi: 10.1007/978-3-030-20315-3_5. Cancer Treat Res. 2019. PMID: 31317481
Incidence of venous thromboembolism and its effect on survival among patients with common cancers.
Chew HK, Wun T, Harvey D, Zhou H, White RH. Chew HK, et al. Among authors: wun t. Arch Intern Med. 2006 Feb 27;166(4):458-64. doi: 10.1001/archinte.166.4.458. Arch Intern Med. 2006. PMID: 16505267
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer.
Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, Flaumenhaft R; CATIQ Investigators11. Zwicker JI, et al. Among authors: wun t. JCI Insight. 2019 Feb 21;4(4):e125851. doi: 10.1172/jci.insight.125851. eCollection 2019 Feb 21. JCI Insight. 2019. PMID: 30652973 Free PMC article. Clinical Trial.
229 results
Jump to page
Feedback